vs

Side-by-side financial comparison of ALEXANDERS INC (ALX) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

ALEXANDERS INC is the larger business by last-quarter revenue ($53.3M vs $39.6M, roughly 1.3× SBC Medical Group Holdings Inc). On growth, ALEXANDERS INC posted the faster year-over-year revenue change (-4.7% vs -10.9%). Over the past eight quarters, ALEXANDERS INC's revenue compounded faster (-6.9% CAGR vs -15.0%).

Alexander's, Inc. is a real estate investment trust that owns 7 properties in New York metropolitan area, including 731 Lexington Avenue, the headquarters of Bloomberg L.P. It is controlled by Vornado Realty Trust. It was founded by George Farkas and Louis Schwadron in 1928.

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

ALX vs SBC — Head-to-Head

Bigger by revenue
ALX
ALX
1.3× larger
ALX
$53.3M
$39.6M
SBC
Growing faster (revenue YoY)
ALX
ALX
+6.2% gap
ALX
-4.7%
-10.9%
SBC
Faster 2-yr revenue CAGR
ALX
ALX
Annualised
ALX
-6.9%
-15.0%
SBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALX
ALX
SBC
SBC
Revenue
$53.3M
$39.6M
Net Profit
$14.2M
Gross Margin
73.1%
Operating Margin
32.5%
Net Margin
35.9%
Revenue YoY
-4.7%
-10.9%
Net Profit YoY
117.2%
EPS (diluted)
$0.75
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALX
ALX
SBC
SBC
Q4 25
$53.3M
$39.6M
Q3 25
$53.4M
$43.4M
Q2 25
$51.6M
$43.4M
Q1 25
$54.9M
$47.3M
Q4 24
$55.9M
$44.4M
Q3 24
$55.7M
$53.1M
Q2 24
$53.4M
$53.1M
Q1 24
$61.4M
$54.8M
Net Profit
ALX
ALX
SBC
SBC
Q4 25
$14.2M
Q3 25
$6.0M
$12.8M
Q2 25
$6.1M
$2.5M
Q1 25
$12.3M
$21.5M
Q4 24
$6.5M
Q3 24
$6.7M
$2.8M
Q2 24
$8.4M
$18.5M
Q1 24
$16.1M
$18.8M
Gross Margin
ALX
ALX
SBC
SBC
Q4 25
73.1%
Q3 25
70.6%
Q2 25
69.2%
Q1 25
79.7%
Q4 24
76.3%
Q3 24
81.5%
Q2 24
74.2%
Q1 24
72.1%
Operating Margin
ALX
ALX
SBC
SBC
Q4 25
32.5%
Q3 25
36.6%
Q2 25
33.6%
Q1 25
51.1%
Q4 24
10.6%
Q3 24
26.1%
Q2 24
51.4%
Q1 24
44.6%
Net Margin
ALX
ALX
SBC
SBC
Q4 25
35.9%
Q3 25
11.2%
29.6%
Q2 25
11.9%
5.7%
Q1 25
22.4%
45.4%
Q4 24
14.7%
Q3 24
12.0%
5.3%
Q2 24
15.7%
34.8%
Q1 24
26.2%
34.2%
EPS (diluted)
ALX
ALX
SBC
SBC
Q4 25
$0.75
$0.15
Q3 25
$1.16
$0.12
Q2 25
$1.19
$0.02
Q1 25
$2.40
$0.21
Q4 24
$2.39
$0.05
Q3 24
$1.30
$0.03
Q2 24
$1.63
$0.20
Q1 24
$3.14
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALX
ALX
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$128.2M
$164.1M
Total DebtLower is stronger
$42.8M
Stockholders' EquityBook value
$109.2M
$248.3M
Total Assets
$1.1B
$380.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALX
ALX
SBC
SBC
Q4 25
$128.2M
$164.1M
Q3 25
$286.1M
$127.4M
Q2 25
$313.0M
$152.7M
Q1 25
$319.9M
$132.1M
Q4 24
$338.5M
$125.0M
Q3 24
$354.8M
$137.4M
Q2 24
$410.9M
Q1 24
$526.3M
Total Debt
ALX
ALX
SBC
SBC
Q4 25
$42.8M
Q3 25
$21.1M
Q2 25
$7.1M
Q1 25
$6.9M
Q4 24
$6.6M
Q3 24
$823.2K
Q2 24
Q1 24
Stockholders' Equity
ALX
ALX
SBC
SBC
Q4 25
$109.2M
$248.3M
Q3 25
$128.3M
$248.0M
Q2 25
$145.4M
$244.6M
Q1 25
$163.1M
$226.4M
Q4 24
$176.9M
$195.1M
Q3 24
$190.7M
$205.0M
Q2 24
$212.5M
$8.8M
Q1 24
$230.1M
$9.0M
Total Assets
ALX
ALX
SBC
SBC
Q4 25
$1.1B
$380.4M
Q3 25
$1.3B
$321.4M
Q2 25
$1.3B
$315.3M
Q1 25
$1.3B
$284.6M
Q4 24
$1.3B
$266.1M
Q3 24
$1.4B
$296.5M
Q2 24
$1.5B
$19.5M
Q1 24
$1.4B
$19.8M
Debt / Equity
ALX
ALX
SBC
SBC
Q4 25
0.17×
Q3 25
0.09×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALX
ALX
SBC
SBC
Operating Cash FlowLast quarter
$73.4M
$52.0M
Free Cash FlowOCF − Capex
$51.2M
FCF MarginFCF / Revenue
129.3%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
3.66×
TTM Free Cash FlowTrailing 4 quarters
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALX
ALX
SBC
SBC
Q4 25
$73.4M
$52.0M
Q3 25
$-9.3M
$-20.9M
Q2 25
$43.6M
$-8.3M
Q1 25
$15.7M
$1.9M
Q4 24
$54.1M
$-7.3M
Q3 24
$-5.0M
$5.0M
Q2 24
$11.5M
$19.2M
Q1 24
$16.8M
$3.7M
Free Cash Flow
ALX
ALX
SBC
SBC
Q4 25
$51.2M
Q3 25
$-20.9M
Q2 25
$-8.6M
Q1 25
$1.7M
Q4 24
$-7.9M
Q3 24
$4.6M
Q2 24
$18.3M
Q1 24
$3.0M
FCF Margin
ALX
ALX
SBC
SBC
Q4 25
129.3%
Q3 25
-48.3%
Q2 25
-19.9%
Q1 25
3.5%
Q4 24
-17.8%
Q3 24
8.7%
Q2 24
34.5%
Q1 24
5.4%
Capex Intensity
ALX
ALX
SBC
SBC
Q4 25
2.0%
Q3 25
0.1%
Q2 25
0.7%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.8%
Q2 24
1.6%
Q1 24
1.3%
Cash Conversion
ALX
ALX
SBC
SBC
Q4 25
3.66×
Q3 25
-1.55×
-1.63×
Q2 25
7.12×
-3.39×
Q1 25
1.28×
0.09×
Q4 24
-1.12×
Q3 24
-0.75×
1.77×
Q2 24
1.37×
1.04×
Q1 24
1.04×
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALX
ALX

Segment breakdown not available.

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons